36BZ

iShares MSCI China A UCITS USD

ETFs & Funds · EUR · F

36BZETF

Price

€5.324

+0.91%

Cap

Earnings

30d Trend

+1.3%

36BZ
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityLow

20% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level25
Momentum64
Technical52
Fund Quality52
Cost Efficiency83

Raw weighted: 66×Macro 0.99 (1%)=65

RISK

25/100
90d Volatility
19.6%Low
ATR %
1.3%Low daily moves
Max Drawdown (1Y)
-7.5%Resilient

MOMENTUM

64/100
6-1M Momentum
+9.5%Positive
1M Return
+3.2%Stable

TECHNICAL

52/100
RSI (14)
55.6Neutral
Price vs SMA200
+9.1%Bullish trend
MACD
-0.01Bearish momentum
Bollinger Band
58%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.141Noisy/choppy

FUND QUALITY

52/100
Holdings
10 positionsConcentrated
Domicile
Ireland (tax-efficient)15% US withholding tax

COST EFFICIENCY

83/100
Expense Ratio
0.00%Ultra-low cost
Fund Size (AUM)
$1.8BMid-size

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months44
3-12 months64
1-5+ years70

12-24 month value thesis — fundamentally underpriced

BRAIN47'S ASSESSMENT

I rate iShares MSCI China A UCITS USD at 65/100 — a STRONG reading on the Brain47 Signal. The strongest factor is cost efficiency at 83/100. I classify this as a growth position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

+3.2%

3 MONTHS

+3.8%

12 MONTHS

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

12-24 month value thesis — fundamentally underpriced. Cost Efficiency (83) and low-risk profile are the primary strengths. Historical volatility is normal at 20%. I classify this as a growth position — positive trend direction combined with solid fundamentals points to capital appreciation.

growthScore: 65/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.